Literature DB >> 20553431

Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates.

Carey A Greco1, Jerry G Zhang, Miloslav Kalab, Qi-Long Yi, Sandra M Ramirez-Arcos, Maria I C Gyongyossy-Issa.   

Abstract

BACKGROUND: Platelet additive solutions (PASs) are an alternative to plasma for the storage of platelet concentrates (PCs). However, little is known about the effect of PAS on the growth dynamics of contaminant bacteria. Conversely, there have been no studies on the influence of bacteria on platelet (PLT) quality indicators when suspended in PAS. STUDY DESIGN AND METHODS: Eight buffy coats were pooled, split, and processed into PCs suspended in either plasma or PAS (SSP+, MacoPharma). PCs were inoculated with 10 and 100 colony-forming units (CFUs)/bag of either Serratia liquefaciens or Staphylococcus epidermidis. Bacterial growth was measured over 5 days by colony counts and bacterial biofilm formation was assayed by scanning electron microscopy and crystal violet staining. Concurrently, PLT markers were measured by an assay panel and flow cytometry.
RESULTS: S. liquefaciens exhibited an apparent slower doubling time in plasma-suspended PCs (plasma-PCs). Biofilm formation by S. liquefaciens and S. epidermidis was significantly greater in PCs stored in plasma than in PAS. Although S. liquefaciens altered several PLT quality markers by Days 3 to 4 postinoculation in both PAS- and plasma-PCs, S. epidermidis contamination did not produce measurable PLT changes.
CONCLUSIONS: S. liquefaciens can be detected more quickly in PAS-suspended PCs (PAS-PCs) than in plasma-PCs by colony counting. Furthermore, reduced biofilm formation by S. liquefaciens and S. epidermidis during storage in PAS-PCs increases bacteria availability for sampling detection. Culture-based detection remains the earliest indicator of bacterial presence in PAS-PCs, while changes of PLT quality can herald S. liquefaciens contamination when in excess of 10(8) CFUs/mL.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553431     DOI: 10.1111/j.1537-2995.2010.02726.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.

Authors:  Eva María Plaza; María Luisa Lozano; Isabel Sánchez Guiu; José Manuel Egea; Vicente Vicente; Laura Collantes De Terán; José Rivera
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

2.  Biofilm Formation and Quorum-Sensing-Molecule Production by Clinical Isolates of Serratia liquefaciens.

Authors:  Sara Remuzgo-Martínez; María Lázaro-Díez; Celia Mayer; Maitane Aranzamendi-Zaldumbide; Daniel Padilla; Jorge Calvo; Francesc Marco; Luis Martínez-Martínez; José Manuel Icardo; Ana Otero; José Ramos-Vivas
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

Review 3.  Microbiological Screening of Platelet Concentrates in Europe.

Authors:  Marcel Prax; Isabelle Bekeredjian-Ding; Oleg Krut
Journal:  Transfus Med Hemother       Date:  2019-03-20       Impact factor: 3.747

Review 4.  Platelet Additive Solutions: A Review of the Latest Developments and Their Clinical Implications.

Authors:  Pieter F van der Meer; Dirk de Korte
Journal:  Transfus Med Hemother       Date:  2018-03-09       Impact factor: 3.747

5.  Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases.

Authors:  Farhad Razjou; Abolfazl Dabir Moghaddam; Gharib Karimi; Maryam Zadsar
Journal:  Iran J Pathol       Date:  2017-04-01

6.  The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets.

Authors:  Maria Loza-Correa; Juan A Ayala; Iris Perelman; Keith Hubbard; Miloslav Kalab; Qi-Long Yi; Mariam Taha; Miguel A de Pedro; Sandra Ramirez-Arcos
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.